Access cutting-edge pneumonia treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.
Access pneumonia specialists in Columbus at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pneumonia treatment provided free
A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring supplemental oxygen therapy. The purpose of this study is to examine the safety, tolerability and efficacy of AV-001 Injection administration daily to the earlier of day 28 or EOT (day prior to hospital discharge). A total of 120 eligible patients (20 patients in each of cohort 1, 2 and 3 and 60 patients in cohort 4) will be recruited from up
Sponsor: Vasomune Therapeutics, Inc.
Check if you qualify for this pneumonia clinical trial in Columbus, OH
If you're searching for pneumonia treatment options in Columbus, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pneumonia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.